Bangalore’s IPO pipeline includes both venture-backed technology companies and established manufacturing, engineering, and pharmaceutical businesses. That mix creates different readiness problems. A SaaS company at Series D worries about its ESOP pool and four rounds of convertible instruments. A manufacturing SME out of Peenya worries about restated financials and capacity certification. Sapient Services works with both, on pre-IPO readiness, valuation, SEBI ICDR compliance, and DRHP support, for companies heading toward BSE SME, NSE Emerge, or the mainboard.
In Brief
|
SEBI’s ICDR Regulations apply the same way whether a company is in Bangalore, Mumbai, or Chennai. What changes isn’t the rule, it’s the company. Bangalore sends SEBI a lot of businesses with complicated funding histories: three or four rounds of SAFE, CCD, and priced equity, ESOP pools nobody formally reconciled, and, sometimes, a manufacturing layer sitting inside a company that markets itself as pure software.
We’ve written up the full ICDR eligibility framework, including Regulation 6(1) and 6(2), on our IPO Advisory Services in Delhi page. This one sticks to what actually shows up when a Bangalore company walks in the door.
Venture-backed tech companies at Series C and beyond usually can’t meet Regulation 6(1)’s profitability test: average operating profit of at least Rs 15 crore during the preceding three years, with a profit in each of those years, not any three years out of five. Most growth-stage SaaS or fintech companies don’t clear that. They go through Regulation 6(2) instead, the book-building route, which needs at least 75% of the net offer allotted to Qualified Institutional Buyers and carries no profitability test. If that 75% threshold isn’t met, the full subscription gets refunded.
The other group is manufacturing, pharma, and engineering SMEs out of Peenya, Bommasandra, and Electronic City, weighing NSE Emerge or BSE SME. Their questions are more conventional: restated financials, the Rs 1 crore EBITDA threshold introduced under the 2025 SME amendments, installed-capacity disclosure.
Family businesses moving off informal governance sit in between, and they usually need the most work on board composition and related-party documentation before a merchant banker gets involved.
Capillary Technologies, the Bengaluru loyalty and customer-engagement SaaS company, filed its DRHP on June 18, 2025, proposing a Rs 430 crore fresh issue and an OFS of up to 1.83 crore shares. By the time the issue opened in November, the structure had changed: a finalised Rs 345 crore fresh issue and an OFS of about 92 lakh shares, Rs 877.5 crore total, price band Rs 549 to 577. It listed on November 21 at a slight discount, then traded above issue price within the hour, closing day one on subscription near 53 times.
The gap between the DRHP numbers and the final structure isn’t unusual. Issue sizing gets revisited as the deal gets closer to launch and investor demand becomes clearer. What’s harder to fix at the last minute is the paperwork behind it: cap table, ESOP records, and related-party disclosures, consistent enough that SEBI doesn’t send the DRHP back with questions.
Pre-IPO readiness review: before a merchant banker is even involved, we reconcile the ESOP pool against the cap table and check related-party transactions for arm’s-length documentation.
SEBI ICDR eligibility assessment: which route fits, Regulation 6(1), 6(2), or the SME platform, and what has to change first.
Valuation: pre-IPO and DRHP-stage reports from our IBBI Registered Valuers, with peer benchmarking.
Technical certification: where the offer document needs installed-capacity or capacity-utilisation disclosure, we arrange Chartered Engineer certification for that part of the business.
Post-listing support: LODR filings and monitoring-agency reporting once the company is trading.
Under Regulation 5(2), a company generally can’t file for an IPO while it has outstanding convertible securities or rights to receive equity shares. ESOPs are the standard exception, and a 2025 amendment extended that to fully-exercised stock appreciation rights. But a SAFE and a CCD aren’t the same instrument, and shouldn’t be treated as interchangeable just because both eventually convert into equity. Whether a given SAFE creates an eligibility problem depends on its actual terms. Get it reviewed before you assume either way, and settle or convert whatever needs settling with enough runway before the offer document stage, not the week before.
Factor | Mainboard (Regulation 6(2)) | SME |
|---|---|---|
Post-issue paid-up capital | No fixed ceiling | Capped at Rs 25 crore |
Profitability | None required under 6(2) | EBITDA of at least Rs 1 crore, 2 of last 3 years |
QIB allocation | At least 75% of the net offer | Not mandated |
Underwriting | Not mandatory | Mandatory, 100%, 15% by the merchant banker |
Migrating from SME to mainboard isn’t automatic once a company crosses the Rs 25 crore paid-up capital ceiling. NSE’s current criteria, effective May 2025, ask for average market capitalisation of at least Rs 100 crore, positive operating profit in two of the last three years, minimum revenue of Rs 100 crore in the preceding financial year, and promoter holding of at least 50% of what they held at listing. Companies planning that path should build toward these numbers well before they think they’re close.
Sapient has supported DRHP preparation and regulatory documentation for listed companies including IKIO Lighting, Greaves Electric Mobility, Proventus Agrocom, MV Electrosystems, Metalman Auto, Viney Corporation, and SAEL. The team is IBBI Registered Valuers, Chartered Engineers, and Chartered Accountants, brought in as an assignment needs them, working alongside the merchant banker rather than separately from them.
The merchant banker runs the transaction itself: filing, book building, listing. Sapient handles the layer underneath it, certifications, valuation reports, and the cap-table and disclosure cleanup that shapes how many rounds of SEBI queries a DRHP goes through before it clears.
Not in the regulation. The ICDR framework is national. What’s different is the client mix: more multi-round, ESOP-heavy cap tables here than in cities with an older base of listed companies.
Yes, through Regulation 6(2), provided at least 75% of the net offer goes to Qualified Institutional Buyers. It’s the route that’s taken loss-making companies such as Zomato and Meesho to the mainboard.
Getting ESOP pools and multiple rounds of SAFE, CCD, and priced equity into one structure that matches across the cap table, offer document, and promoter contribution calculation.
Yes, if the offer document needs installed-capacity disclosure, which applies to anyone manufacturing physical products.
Two to three weeks is typical if the documentation is already organised. Messier cap tables take longer.
No. Sapient operates from New Delhi and serves clients across India, including Bangalore, with site visits arranged as needed.
Not while they’re outstanding, unless they fall under one of the Regulation 5(2) exceptions. They typically need to convert or settle well before the offer document stage.
Four things worth sorting first, because a merchant banker’s own due diligence will ask for them anyway:
Call +91 9540162888 or email valuation@sapientservices.com to go through where your company stands on these before you approach a merchant banker.
Related Sapient Services
